cholestyramine resin has been researched along with Basedow Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, PP | 1 |
| Er, C; Sule, AA | 1 |
| Escobar-Jiménez, F; Fernández-García, D; Quesada-Charneco, M; Reyes-García, R; Rozas-Moreno, P; Sebastián-Ochoa, A | 1 |
| Chen, SP; Kuo, SW; Lee, CH; Li, JC; Pei, D; Tsai, WC; Wang, TF; Wei, CL; Wu, DA | 1 |
| Burman, KD; Solomon, BL; Wartofsky, L | 1 |
| Burman, KD; Cranston, T; Porter, L; Sfikakis, PP; Smallridge, RC; Solomon, BL; Tsokos, GC | 1 |
3 trial(s) available for cholestyramine resin and Basedow Disease
| Article | Year |
|---|---|
The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Cholestyramine Resin; Drug Administration Schedule; Drug Therapy, Combination; Female; Graves Disease; Humans; Ion Exchange Resins; Male; Middle Aged; Propranolol; Propylthiouracil; Receptors, Thyroid Hormone; Thyroid Function Tests; Thyroxine; Time Factors; Treatment Outcome; Triiodothyronine | 2005 |
Adjunctive cholestyramine therapy for thyrotoxicosis.
Topics: Adult; Atenolol; Chemotherapy, Adjuvant; Cholestyramine Resin; Double-Blind Method; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Thyroid Hormones; Thyrotoxicosis | 1993 |
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis.
Topics: Antithyroid Agents; Biomarkers; Cholestyramine Resin; E-Selectin; Female; Graves Disease; Humans; Intercellular Adhesion Molecule-1; Male; Methimazole; Multivariate Analysis; Randomized Controlled Trials as Topic; Receptors, Interleukin-2; Thyroid Hormones; Thyrotoxicosis | 1997 |
3 other study(ies) available for cholestyramine resin and Basedow Disease
| Article | Year |
|---|---|
Use of Lithium in Hyperthyroidism Secondary to Graves' Disease: A Case Report.
Topics: Adult; Blast Crisis; Carbonates; Cholestyramine Resin; Graves Disease; Humans; Hyperthyroidism; Iodine; Iodine Radioisotopes; Lithium; Male; Thyrotropin | 2022 |
Cholestyramine as monotherapy for Graves' hyperthyroidism.
Topics: Adult; Carbimazole; China; Cholestyramine Resin; Female; Graves Disease; Humans; Hyperthyroidism; Patient Admission; Sepsis; Thyroid Gland; Treatment Outcome | 2016 |
Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy.
Topics: Adult; Antithyroid Agents; Cholestyramine Resin; Drug Resistance; Drug Therapy, Combination; Ehlers-Danlos Syndrome; Female; Graves Disease; Humans; Iodine; Methimazole; Propranolol; Treatment Outcome | 2008 |